Page 121 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation

Workflow optimization of MTV in DLBCL
19. McGraw KO, Wong SP (1996) Forming inferences about some intraclass correlation coefficients.
Psychol Methods. 1:30–46.
20. Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for
reliability research. J Chiropr Med. 15:155–163.
21. Portney LG, Watkins MP (2009) Intraclass correlation coefficient (ICC). In: Foundations of clinical
research: applications to practice. Pearson Prentice Hall, Upper Saddle River, New Jersey, pp 588–598.
22. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of
clinical measurement. Lancet. 1:307–310.
23. Barrington SF, de Vet HCW, Mikhaeel NG, et al. (2018) Automated segmentation of total tumour burden in DLBCL: which method is most successful? 7thPILM, Menton [Abstract V1] https://d r i v e . g o o g l e . c o m / d r i v e / f o l d e r s /1a0q5uYLBx6HqcUjBxTryiWPUOWFTJGLG;
24. Ceriani L, Milan L, Johnson PWM et al (2019) Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume. Eur J Nucl Med Mol Imaging. 46:1334– 1344.
25. Barrington SF, Meignan MA (2019) Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden. J Nucl Med. 60:1096–1102.
26. Parvez A, Tau N, Hussey D, Maganti M, Metser U (2018) (18)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival. Ann Nucl Med. 32:410–416.
119
5